Does OLAPARIB Cause Metastases to bone? 145 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 145 reports of Metastases to bone have been filed in association with OLAPARIB (Lynparza). This represents 0.8% of all adverse event reports for OLAPARIB.
145
Reports of Metastases to bone with OLAPARIB
0.8%
of all OLAPARIB reports
19
Deaths
24
Hospitalizations
How Dangerous Is Metastases to bone From OLAPARIB?
Of the 145 reports, 19 (13.1%) resulted in death, 24 (16.6%) required hospitalization, and 4 (2.8%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 145 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which OLAPARIB Alternatives Have Lower Metastases to bone Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL